RA

Rishav Aggarwal

Director DIN 02558239
DIN 02558239 First appointment Oct 2009
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Rishav Aggarwal

Data last updated:

Rishav Aggarwal was an Additional Director at Altamed Laboratories Private Limited (from 2009) and Director at Paresha Biocare Private Limited (from 2017).

DIN 02558239
First Appointment 01 Oct 2009
Oldest Company Age 17 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Altamed Laboratories Private Limited U93000CH2009PTC031508
Additional Director01 Oct 20092009Strike Off
Paresha Biocare Private Limited U74999PB2017PTC046584
Director08 Jun 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Altamed Laboratories Private Limited
Paresha Biocare Private Limited
Premium access

Shareholding and investment profile for Rishav Aggarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rishav Aggarwal

Rishav Aggarwal was first appointed on 01 Oct 2009 as Additional Director at Altamed Laboratories Private Limited. The most recent appointment on record is 08 Jun 2017 at Paresha Biocare Private Limited.

Rishav Aggarwal held 2 earlier board appointments: Altamed Laboratories Private Limited (Additional Director, from 01 Oct 2009); Paresha Biocare Private Limited (Director, from 08 Jun 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available